However, the effects of CALR on angiogenesis in tumor models have demonstrated that CALR undergoes N-terminal cleavage to generate the CALR fragment, vasostatin, that acts as an inhibitor of angiogenesis by preventing endothelial cell adhesion (162, 163). The gene discussed is CALR; the disease is neoplasm.